
SyntheticGestalt (Shinjuku, Tokyo; CEO Koki Shimada; hereinafter "our company") is pleased to announce that our company has successfully identified new target genes for cell differentiation necessary for realizing liver regeneration through AI utilization.
Our company aims to develop AI for scientific discovery and participates in the Moonshot R&D Program (hereinafter "Moonshot")*1 Goal 3 project "Co-evolution of Human and AI-Robots to Expand Science Frontiers" receiving support for its pioneering vision.
Our role in the project is to develop AI that generates hypotheses for gene regulatory networks. To achieve this purpose, our company is conducting two research and development activities:
1. Development of AI foundation models handling gene expression data
2. Application to scientific challenges
Our company has now successfully used science AI to automatically discover important target genes needed to induce the necessary component cells from iPS cells for liver regeneration.
Specifically, by narrowing down from approximately 10 million gene combinations and having them evaluated by experts, our AI was able to discover unpublished genes that serve as new targets for cell differentiation. This achievement would require extensive research time and costs even for top researchers, but by compressing these through AI discoveries, our company has significantly contributed to the development of foundational technologies enabling liver regeneration. In the future, incorporating robots will further accelerate these discoveries.
Our company is working toward creating a world where AI improves the success rate of scientific research, shortens research and development timelines, and generates more scientific innovations through efficient use of research resources. Our company will continue contributing to the acceleration of cutting-edge scientific research, particularly in life sciences, by developing and providing advanced AI foundation models related to gene expression.
*1 Moonshot: A research and development program established by the Japanese government in 2018, aimed at creating Japan-originated innovations and promoting research and development based on bold ideas. This work was supported by JST Moonshot R&D JPMJMS2033
About SyntheticGestalt
SyntheticGestalt develops AI technology specialized in molecular information. In 2024 and 2025, we unveiled the world's largest molecule-specific foundation model at NVIDIA GTC. Our molecular foundation model resolves accuracy challenges faced by conventional molecular AI. We aim to apply this technology across various fields including pharmaceuticals, cosmetics, agrochemicals, and new materials. Our mission is to contribute to the advancement of civilization through AI-driven innovations.
